Literature DB >> 10379450

Catheter-associated infections in urology: possible use of silver-impregnated catheters and the Erlanger silver catheter.

W Rösch1, S Lugauer.   

Abstract

Indwelling urinary catheters play a very important part in urology. However, their use is accompanied by a considerable increase in the risk of nosocomial urinary tract infections. The pathophysiological cause is ascribed to pathogens that adhere to the catheter surface, proliferate and produce a biofilm. In addition to aseptic techniques, modification of the catheter material to confer antimicrobial activity plays an essential part in the prevention of catheter-related urinary tract infections. The antimicrobial efficacy of silver against gram-positive and gram-negative bacteria is well known and amply shown in vitro. The efficacy of silver-impregnated catheters is critically dependent on both the chemical structure of the incorporated silver and the way the silver has been combined with the basic catheter material. Hence, clinical studies on silver-modified catheters have so far given inconsistent results. The new technology of the Erlanger silver catheter offers the opportunity of an effective reduction in catheter-related infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10379450     DOI: 10.1007/bf02561624

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  25 in total

1.  Technical advances in the prevention of urinary tract infection.

Authors:  R E DESAUTELS; C W WALTER; R C GRAVES; J H HARRISON
Journal:  J Urol       Date:  1962-03       Impact factor: 7.450

2.  Silver-resistant mutants of Escherichia coli display active efflux of Ag+ and are deficient in porins.

Authors:  X Z Li; H Nikaido; K E Williams
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

3.  Prevention of catheter-associated urinary-tract infections by use of silver-impregnated catheters.

Authors:  T Lundeberg
Journal:  Lancet       Date:  1986-11-01       Impact factor: 79.321

4.  Multiple parameters for the comprehensive evaluation of the susceptibility of Escherichia coli to the silver ion.

Authors:  G Zhao; S E Stevens
Journal:  Biometals       Date:  1998-01       Impact factor: 2.949

5.  Reduced rates of catheter-associated infection by use of a new silver-impregnated central venous catheter.

Authors:  M Böswald; S Lugauer; A Regenfus; G G Braun; P Martus; C Geis; J Scharf; T Bechert; J Greil; J P Guggenbichler
Journal:  Infection       Date:  1999       Impact factor: 3.553

6.  In vitro evaluation of the efficacy of a silver-coated catheter.

Authors:  M M Gabriel; M S Mayo; L L May; R B Simmons; D G Ahearn
Journal:  Curr Microbiol       Date:  1996-07       Impact factor: 2.188

7.  A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection.

Authors:  D K Riley; D C Classen; L E Stevens; J P Burke
Journal:  Am J Med       Date:  1995-04       Impact factor: 4.965

8.  Long-term studies of urease-induced crystallization in human urine.

Authors:  A Edin-Liljegren; L Grenabo; H Hedelin; S Pettersson; Y H Wang
Journal:  J Urol       Date:  1994-07       Impact factor: 7.450

9.  Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms?

Authors:  N S Morris; D J Stickler; C Winters
Journal:  Br J Urol       Date:  1997-07

Review 10.  A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters.

Authors:  J P Guggenbichler; M Böswald; S Lugauer; T Krall
Journal:  Infection       Date:  1999       Impact factor: 7.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.